Deepcell

About

Deepcell is a biotechnology company based in Menlo Park, California, founded in 2017 as a spinout from Stanford University. The company specializes in AI-powered single-cell analysis technology that combines microfluidics, high-resolution optics, and deep learning. This innovative approach allows for the classification, capture, and enrichment of viable cells based on their morphology, supporting advancements in precision medicine, biological discoveries, and applications in oncology and drug discovery. The core technology, known as the REM-I platform, integrates label-free imaging and AI for morphology-based classification, enabling the isolation of rare cells without labels or destructive preparation. This platform is designed to provide high-dimensional quantitative readouts of cell morphology, facilitating insights into cell biology. Deepcell's services are utilized in various fields, including translational research, diagnostics, and therapeutic development, with applications ranging from tumor profiling to drug screening and quality control in cell therapy manufacturing.